Zai Lab Announces Participation in September Investor Conferences
August 22 2024 - 7:30AM
Business Wire
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the Company’s senior management team will participate in
the following investor conferences in September 2024:
Morgan Stanley 22nd Annual Global
Healthcare Conference Location: New York, New York
Cantor Fitzgerald Global Healthcare
Conference Fireside Chat: Thursday, September 19, 2024, 8:00
a.m. ET in Track 2 Location: New York, New York
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, autoimmune disorders, infectious diseases, and
neuroscience. Our goal is to leverage our competencies and
resources to positively impact human health in China and
worldwide.
For additional information about Zai Lab, please visit
www.zailaboratory.com or follow us at
www.twitter.com/ZaiLab_Global.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240822810993/en/
Investor Relations: Christine Chiou / Lina Zhang +1 (917)
886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com /
lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen +1 (415) 317-7255 /
+86 185 0015 5011 shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Sep 2024 to Oct 2024
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Oct 2023 to Oct 2024